S&P 500   4,080.11 (+3.09%)
DOW   34,589.77 (+2.18%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
S&P 500   4,080.11 (+3.09%)
DOW   34,589.77 (+2.18%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
S&P 500   4,080.11 (+3.09%)
DOW   34,589.77 (+2.18%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
S&P 500   4,080.11 (+3.09%)
DOW   34,589.77 (+2.18%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.21%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)

Medtronic - MDT Stock Forecast, Price & News

$79.04
+2.56 (+3.35%)
(As of 11/30/2022 05:34 PM ET)
Add
Compare
Today's Range
$76.05
$79.07
50-Day Range
$76.13
$88.46
52-Week Range
$75.83
$114.44
Volume
10.61 million shs
Average Volume
6.24 million shs
Market Capitalization
$105.06 billion
P/E Ratio
24.55
Dividend Yield
3.56%
Price Target
$97.79

Medtronic MarketRank™ Forecast

Analyst Rating
Hold
2.22 Rating Score
Upside/​Downside
23.5% Upside
$97.58 Price Target
Short Interest
Healthy
0.72% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.77
Upright™ Environmental Score
News Sentiment
-0.25mentions of Medtronic in the last 14 days
Based on 43 Articles This Week
Insider Trading
Selling Shares
$196,022 Sold Last Quarter
Proj. Earnings Growth
3.99%
From $5.26 to $5.47 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.04 out of 5 stars

Medical Sector

1st out of 1,043 stocks

Electromedical Equipment Industry

1st out of 23 stocks

MDT stock logo

About Medtronic (NYSE:MDT) Stock

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Stock News Headlines

S&P 500 Component DexCom Set For Further Price, Earnings Growth (MDT)
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
Edwards Life Sciences Stock Disaster Could Be Your Bounty (MDT)
Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report.
“The Bull Market Is Officially OVER” 
Bear market expert issues his top 10 stocks for 2023
Intuitive Surgical Stock is Both a Legacy and Next-Gen Play (MDT)
It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQ: ISRG) is turning 22 years old since its U.S. Food and Drug
Barclays Trims Medtronic (NYSE:MDT) Target Price to $85.00
“The Bull Market Is Officially OVER” 
Bear market expert issues his top 10 stocks for 2023
Should You Buy Medtronic Stock At $80?
Medtronic (NYSE:MDT) Issues FY23 Earnings Guidance
Medtronic (NYSE:MDT) Price Target Cut to $102.00
Medtronic (NYSE:MDT) PT Lowered to $90.00
Medtronic (NYSE:MDT) Given New $90.00 Price Target at Cowen
Medtronic (NYSE:MDT) Downgraded to Market Perform at Oppenheimer
Truist Financial Lowers Medtronic (NYSE:MDT) Price Target to $84.00
Medtronic (NYSE:MDT) Lowered to "Neutral" at Citigroup
Medtronic (NYSE:MDT) Hits New 52-Week Low After Analyst Downgrade
Medtronic (NYSE:MDT) Price Target Cut to $80.00
See More Headlines
Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Company Calendar

Ex-Dividend for 10/14 Dividend
9/22/2022
Dividend Payable
10/14/2022
Last Earnings
11/22/2022
Today
11/30/2022
Next Earnings (Estimated)
2/21/2023
Fiscal Year End
4/30/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
58505510
Employees
95,000
Year Founded
1949

Price Target and Rating

Average Stock Price Forecast
$97.58
High Stock Price Forecast
$135.00
Low Stock Price Forecast
$77.00
Forecasted Upside/Downside
+23.7%
Consensus Rating
Hold
Rating Score (0-4)
2.22
Research Coverage
23 Analysts

Profitability

Net Income
$5.04 billion
Pretax Margin
18.27%

Debt

Sales & Book Value

Annual Sales
$31.69 billion
Cash Flow
$7.90 per share
Book Value
$39.17 per share

Miscellaneous

Outstanding Shares
1,329,153,000
Free Float
1,325,298,000
Market Cap
$105.06 billion
Optionable
Optionable
Beta
0.77

Social Links


Key Executives

  • Mr. Geoffrey Straub Martha (Age 52)
    Chairman & CEO
    Comp: $4.35M
  • Ms. Karen L. ParkhillMs. Karen L. Parkhill (Age 57)
    EVP, CFO, IT & Enterprise Excellence
    Comp: $2.41M
  • Mr. Ivan K. Fong (Age 61)
    Exec. VP, Gen. Counsel & Sec.
    Comp: $985.57k
  • Mr. Robert J. W. ten Hoedt (Age 62)
    Exec. VP & Pres of Global Regions
    Comp: $2.02M
  • Mr. Robert John WhiteMr. Robert John White (Age 59)
    Exec. VP & Pres of Medical Surgical Portfolio
    Comp: $2M
  • Mr. Mark Ploof
    Sr. VP of Global Operations and Bus. Services
  • Ms. Jennifer M. Kirk (Age 47)
    Principal Accounting Officer, Global Controller & Chief Accounting Officer
  • Dr. Laura Mauri M.D.
    M.Sc., Sr. VP and Chief Scientific, Medical & Regulatory Officer
  • Mr. Sean Lennon
    Chief Information Officer
  • Mr. Ryan Weispfenning
    VP of Investor Relations













MDT Stock - Frequently Asked Questions

Should I buy or sell Medtronic stock right now?

23 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 1 sell rating, 16 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
View MDT analyst ratings
or view top-rated stocks.

What is Medtronic's stock price forecast for 2023?

23 equities research analysts have issued twelve-month price objectives for Medtronic's stock. Their MDT share price forecasts range from $77.00 to $135.00. On average, they predict the company's stock price to reach $97.58 in the next year. This suggests a possible upside of 24.9% from the stock's current price.
View analysts price targets for MDT
or view top-rated stocks among Wall Street analysts.

How have MDT shares performed in 2022?

Medtronic's stock was trading at $103.45 at the start of the year. Since then, MDT stock has decreased by 24.5% and is now trading at $78.15.
View the best growth stocks for 2022 here
.

Are investors shorting Medtronic?

Medtronic saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 9,630,000 shares, an increase of 19.8% from the October 15th total of 8,040,000 shares. Based on an average trading volume of 6,040,000 shares, the short-interest ratio is presently 1.6 days. Approximately 0.7% of the shares of the stock are sold short.
View Medtronic's Short Interest
.

When is Medtronic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our MDT earnings forecast
.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) released its earnings results on Tuesday, November, 22nd. The medical technology company reported $1.30 EPS for the quarter, topping analysts' consensus estimates of $1.28 by $0.02. The medical technology company earned $7.59 billion during the quarter, compared to analyst estimates of $7.70 billion. Medtronic had a net margin of 14.03% and a trailing twelve-month return on equity of 13.52%. The firm's quarterly revenue was down 3.3% compared to the same quarter last year. During the same period in the prior year, the company earned $1.32 EPS.
Read the conference call transcript
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Thursday, August 18th. Stockholders of record on Friday, September 23rd will be given a dividend of $0.68 per share on Friday, October 14th. This represents a $2.72 annualized dividend and a dividend yield of 3.48%. The ex-dividend date of this dividend is Thursday, September 22nd.
Read our dividend analysis for MDT
.

Is Medtronic a good dividend stock?

Medtronic (NYSE:MDT) pays an annual dividend of $2.72 per share and currently has a dividend yield of 3.57%. The company has been increasing its dividend for 45 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 84.47%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MDT will have a dividend payout ratio of 49.73% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDT.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its FY23 earnings guidance on Tuesday, November, 22nd. The company provided earnings per share (EPS) guidance of $5.25-5.30 for the period, compared to the consensus EPS estimate of $5.53.

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.32%), BlackRock Inc. (8.73%), State Street Corp (4.44%), Massachusetts Financial Services Co. MA (2.57%), Bank of New York Mellon Corp (1.46%) and Lazard Asset Management LLC (1.05%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Omar Ishrak, Richard H Anderson, Richard H Anderson, Robert John White and Sean Salmon.
View institutional ownership trends
.

How do I buy shares of Medtronic?

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $78.15.

How much money does Medtronic make?

Medtronic (NYSE:MDT) has a market capitalization of $103.87 billion and generates $31.69 billion in revenue each year. The medical technology company earns $5.04 billion in net income (profit) each year or $3.22 on an earnings per share basis.

How many employees does Medtronic have?

The company employs 95,000 workers across the globe.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for the company is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879.

This page (NYSE:MDT) was last updated on 11/30/2022 by MarketBeat.com Staff